市場調査レポート

商品コード

1633597

血液学の市場規模、シェア、成長分析：製品タイプ別、試薬タイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

Hematology Market Size, Share, Growth Analysis, By Product Type (Hematology Analyzers, Flow Cytometers), By Reagent Type (Coagulation Reagents, Flow Cytometry Reagents), By Application, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年01月12日
発行: SkyQuest
ページ情報: 英文 208 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 3,500 504,210円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 4,400 633,864円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 5,300 763,518円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

血液学の世界市場規模は2023年に91億2,000万米ドルと評価され、予測期間（2025-2032年）のCAGRは8.2%で、2024年の98億7,000万米ドルから2032年には185億4,000万米ドルに成長する見通しです。

世界の血液学市場は、貧血、白血病、リンパ腫、凝固障害などの血液疾患の診断とモニタリングに不可欠です。高齢化や生活習慣の影響によるこれらの疾患の有病率の上昇に加え、診断や新規治療開発における技術的進歩が大きな成長の原動力となっています。疾患の早期発見と個別化医療が、先進的な血液学分析装置の需要をさらに押し上げています。しかし、高度な診断機器の高価格や厳格な規制遵守など、市場は課題に直面しています。しかし、AIや機械学習、ポイントオブケア検査、遠隔医療などの技術統合にはビジネスチャンスが残されており、特に資源が限られた環境での診断サービスへのアクセス改善を促進し、既存の障壁にもかかわらず市場の堅調な見通しを約束しています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Roche（Switzerland）
Merck & Co.（USA）
Abbott Laboratories（USA）
Takeda Pharmaceutical Company（Japan）
Siemens Healthineers（Germany）
Alexion Pharmaceuticals（USA）
Sysmex Corporation（Japan）
Novartis（Switzerland）
Amgen（USA）
Bristol-Myers Squibb（USA）
Agilent Technologies（USA）
Bio-Rad Laboratories（USA）
Danaher Corporation（USA）
Thermo Fisher Scientific（USA）
Mindray（China）
Beckman Coulter（USA）
Horiba Ltd.（Japan）
Boule Diagnostics AB（Sweden）
Hoffmann-La Roche Ltd（Switzerland）

結論と推奨事項

Product Code: SQMIG35A2693

Global Hematology Market size was valued at USD 9.12 billion in 2023 and is poised to grow from USD 9.87 billion in 2024 to USD 18.54 billion by 2032, growing at a CAGR of 8.2% during the forecast period (2025-2032).

The global hematology market is essential for diagnosing and monitoring blood disorders such as anemia, leukemia, lymphoma, and coagulation issues. Significant growth is driven by the rising prevalence of these conditions, influenced by an aging population and lifestyle factors, alongside technological advancements in diagnostics and novel treatment developments. Early disease detection and personalized medicine further boost demand for advanced hematology analyzers. However, the market faces challenges, including the high cost of sophisticated diagnostic equipment and rigorous regulatory compliance. Yet, opportunities remain in technology integration, such as AI and machine learning, point-of-care testing, and telemedicine, facilitating improved access to diagnostic services, especially in resource-limited settings, promising a robust market outlook despite existing barriers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hematology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hematology Market Segmental Analysis

Global Hematology Market is segmented by Product Type, Reagent Type, Application, End User and region. Based on Product Type, the market is segmented into Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobinometers and Other. Based on Reagent Type, the market is segmented into Coagulation Reagents, Flow Cytometry Reagents, Immuno-Hematology Reagents and Other. Based on Application, the market is segmented into Anemia, Blood Cancer, Hemophilia, Infection and Other. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, Academic and Research Institutes and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hematology Market

The growth of the global hematology market is significantly fueled by the rising prevalence of hematological disorders, including conditions like leukemia, lymphoma, and anemia. The World Health Organization reported a notable increase in anemia cases worldwide in 2022, highlighting an urgent demand for effective hematology diagnostics. This heightened incidence of blood-related diseases necessitates the use of advanced hematology analyzers capable of accurately measuring red blood cell counts and hemoglobin levels. Consequently, healthcare providers are seeking reliable diagnostic tools to manage the growing number of patients with these disorders, further propelling the expansion of the hematology sector in the global market.

Restraints in the Global Hematology Market

One of the significant restraints affecting the global hematology market is the high cost associated with advanced hematology equipment. Healthcare facilities, especially those in resource-constrained environments, often struggle to afford the substantial acquisition and maintenance expenses associated with state-of-the-art hematology analyzers and flow cytometers. Additionally, the financial burden of upgrading existing technology and training staff in using these sophisticated tools further complicates matters, creating barriers that hinder widespread adoption. As a result, these financial challenges significantly impact the overall growth and development of the hematology market, limiting accessibility and innovation.

Market Trends of the Global Hematology Market

The Global Hematology market is witnessing a significant trend towards the integration of Artificial Intelligence (AI) in diagnostics, predominantly shaping advancements in 2022 and beyond. AI technologies are revolutionizing blood analysis by enabling more precise identification of subtle abnormalities, which is crucial for accurate disease classification. This integration is enhancing the efficiency of hematology analyzers and flow cytometers while simultaneously processing vast datasets to deliver reliable results. Consequently, the adoption of AI is expected to drive market growth, improve diagnostic outcomes, and streamline workflows in laboratories, positioning AI as a pivotal component in the future of hematology diagnostics.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis

Global Hematology Market Size by Product Type & CAGR (2025-2032)

Market Overview
Hematology Analyzers
- 3-Part Differential Analyzers
- 5-Part Differential Analyzers
- Point-of-Care Analyzers
Flow Cytometers
Coagulation Analyzers
Slide Stainers
Centrifuges
Hemoglobinometers
Other

Global Hematology Market Size by Reagent Type & CAGR (2025-2032)

Market Overview
Coagulation Reagents
Flow Cytometry Reagents
Immuno-Hematology Reagents
Other

Global Hematology Market Size by Application & CAGR (2025-2032)

Market Overview
Anemia
Blood Cancer
Hemophilia
Infection
Other

Global Hematology Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Diagnostic Laboratories
Academic and Research Institutes
Other

Global Hematology Market Size & CAGR (2025-2032)

North America (Product Type, Reagent Type, Application, End User)
- US
- Canada
Europe (Product Type, Reagent Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Reagent Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Reagent Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Reagent Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alexion Pharmaceuticals (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mindray (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horiba Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boule Diagnostics AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

血液学の市場規模、シェア、成長分析：製品タイプ別、試薬タイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

Hematology Market Size, Share, Growth Analysis, By Product Type (Hematology Analyzers, Flow Cytometers), By Reagent Type (Coagulation Reagents, Flow Cytometry Reagents), By Application, By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

血液学市場規模：製品タイプ別& CAGR（2025-2032）

血液学市場規模：試薬タイプ別& CAGR（2025-2032）

血液学市場規模：用途別& CAGR（2025-2032）

血液学市場規模：エンドユーザー別& CAGR（2025-2032）

血液学市場規模：地域別& CAGR（2025-2032）